AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,761 | +25.5% | 1,839 | -7.8% | 0.00% | – |
| Q2 2023 | $6,184 | +94.1% | 1,995 | -13.0% | 0.00% | – |
| Q1 2023 | $3,186 | -30.1% | 2,292 | 0.0% | 0.00% | – |
| Q4 2022 | $4,561 | +128.0% | 2,292 | +85.7% | 0.00% | – |
| Q3 2022 | $2,000 | -50.0% | 1,234 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 1,234 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -92.4% | 1,234 | -91.0% | 0.00% | – |
| Q4 2021 | $66,000 | -9.6% | 13,697 | 0.0% | 0.00% | – |
| Q3 2021 | $73,000 | +4.3% | 13,697 | 0.0% | 0.00% | – |
| Q2 2021 | $70,000 | -49.3% | 13,697 | -33.4% | 0.00% | – |
| Q1 2021 | $138,000 | +56.8% | 20,553 | +6.9% | 0.00% | – |
| Q4 2020 | $88,000 | +4.8% | 19,235 | -11.7% | 0.00% | – |
| Q3 2020 | $84,000 | -78.5% | 21,784 | -80.5% | 0.00% | -100.0% |
| Q1 2020 | $390,000 | – | 111,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $144,839,000 | 11.40% |
| Eversept Partners, LP | 4,755,480 | $32,004,380 | 2.41% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $109,116,000 | 1.27% |
| EAM Global Investors LLC | 365,719 | $2,461,000 | 0.68% |
| Signature Wealth Management Partners, LLC | 87,666 | $590,000 | 0.57% |
| Jackson Creek Investment Advisors LLC | 221,043 | $1,488,000 | 0.52% |
| Tranquilli Financial Advisor LLC | 71,414 | $481,000 | 0.39% |
| Hillsdale Investment Management Inc. | 611,200 | $4,113,000 | 0.34% |
| EAM Investors, LLC | 259,873 | $1,749,000 | 0.26% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 180,000 | $1,211,000 | 0.25% |